Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Ferring B.V. et al v. Allergan Inc. et al
Case Number:
1:12-cv-02650
Court:
Nature of Suit:
Judge:
Firms
- Finnegan
- Gibson Dunn
- Jones Day
- Law Office of Elvin Esteves
- Maynard Nexsen
- Theodora Oringher
- Womble Bond
- Zuckerman Spaeder
Companies
Sectors & Industries:
-
August 24, 2021
Jones Day Easily Beats Ferring's $1M Trial Sanctions Motion
A Manhattan federal judge on Tuesday flatly rejected Ferring Pharmaceuticals Inc.'s accusation that Jones Day cost it $1 million in legal fees by forcing it to stand trial in bad faith, denying the drugmaker's motion to sanction the BigLaw firm.
-
August 19, 2021
IP Forecast: Ferring Seeks Sanctions Against Jones Day
Ferring Pharmaceuticals will argue next week that Jones Day should be sanctioned for sparking a patent trial that never should have happened. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.
-
March 26, 2021
Jones Day Fights Ferring's Sanctions Bid Over IP Trial
Jones Day shot back Friday against Ferring Pharmaceuticals' bid for sanctions, arguing that the bulk of its accusations, including that the firm "vexatiously" pushed its former client Serenity Pharmaceuticals into a trial, are based on unsubstantiated claims made against the firm by Serenity in a separate lawsuit.
-
March 08, 2021
Ferring Urges Sanctions For Jones Day Over 'Forced' IP Trial
Ferring Pharmaceuticals asked a New York federal judge Friday to sanction Jones Day, alleging that the firm "vexatiously" pushed its client Serenity Pharmaceuticals into a trial over an anti-diuretic patent and should pay at least $1 million for the excess costs, expenses and attorney fees that Ferring incurred for the trial.
-
June 18, 2018
Ferring Will Face Counterclaims In $165M Patent Deal Row
A New York federal judge has said two pharmaceutical companies run by former Ferring BV researchers may proceed with counterclaims against their former employer over who owns the intellectual property rights to an antidiuretic, finding that they had enough of a financial interest to challenge the patents.
-
June 15, 2016
Ferring, Allergan Patent Dispute Will Head To Trial: Judge
A patent dispute between drug companies Ferring BV and Allergan Inc. will proceed to trial and Ferring won't be allowed to appeal certain resolved claims beforehand, a New York federal judge has ruled.
-
March 20, 2013
Ferring's Trade Secrets Claims Cut In $165M Patent Deal Row
A New York federal judge on Tuesday slashed most claims from Ferring BV's suit accusing two former employees of stealing urology drug trade secrets they used to apply for three patents later sold to Allergan Inc. in a deal worth up to $165 million, saying the claims were untimely.
-
April 09, 2012
Ex-Ferring Workers Made $43M On Stolen Drug Info, Suit Says
Ferring BV on Thursday accused two former researchers of stealing proprietary information about the company's urology drug Minirin in applying for patents that the men later sold to Allergan Inc. in a $43 million deal.